University of Sheffield Medical School, Beech Hill Road, Sheffield, UK.
Eur J Cancer. 2010 Apr;46(6):1069-78. doi: 10.1016/j.ejca.2010.01.022. Epub 2010 Feb 17.
Survival rates following childhood cancer have increased, but survivors experience significant late effects. Long-term follow-up is recommended but imposes an increasing burden on health services. We report prevalence of morbidity in a cohort of survivors from South Yorkshire based on: (i) case-note analysis and (ii) self-reported late effects (parent-reported for under-16s).
Treatment information was taken from case-notes. Comparisons were made between late effects described in notes and reported by 108 survivors aged >16 years, and 45 parents of survivors (12-15 years).
Of 892 patients diagnosed with childhood cancer and some benign conditions registered on hospital databases from January 1990 to December 2005, 337 (37.8%) met eligibility criteria. Ninety-one survivors (16) (84.3%, confidence interval [CI]: 76.0-90.6) reported one or more late effects (mean=3.5; CI: 3.0-4.1), significantly higher than the number of late effects documented in medical notes (mean=0.7; CI: 0.5-0.9; t=-11.26, p<0.001). Thirty-five parents (77.8%, CI: 65.1-90.4) reported late effects for their children (mean=2.7; CI: 2.0-3.4), again higher than medical notes (mean=0.7; CI: 0.4-1.1; t=7.18, p<0.001). More than 30 specialties were involved in survivor care (mean=1.5; CI: 1.4-1.6; range 0-6). Those with more late effects saw more specialties (r=0.51, p<0.001).
We confirm the wide range of late effects experienced by survivors of child cancer, significantly greater than those recorded in medical notes, and requiring care from a range of specialties. Decisions about follow-up need to take account of patient-reported morbidity and concerns.
儿童癌症患者的存活率有所提高,但幸存者仍会出现显著的晚期效应。因此建议进行长期随访,但这给卫生服务带来了越来越大的负担。我们报告了基于以下两方面的南约克郡幸存者队列发病率:(i)病例记录分析和(ii)自我报告的晚期效应(16 岁以下由父母报告)。
从病例记录中获取治疗信息。将记录中描述的晚期效应与 108 名年龄大于 16 岁的幸存者和 45 名幸存者父母(12-15 岁)报告的晚期效应进行比较。
在 1990 年 1 月至 2005 年 12 月期间,从医院数据库中登记的 892 名儿童癌症和一些良性疾病患者中,有 337 名(37.8%)符合入选标准。91 名幸存者(16 岁)(84.3%,置信区间 [CI]:76.0-90.6)报告了一种或多种晚期效应(平均=3.5;CI:3.0-4.1),明显高于医疗记录中记录的晚期效应数量(平均=0.7;CI:0.5-0.9;t=-11.26,p<0.001)。35 名父母(77.8%,CI:65.1-90.4)报告了他们孩子的晚期效应(平均=2.7;CI:2.0-3.4),再次高于医疗记录(平均=0.7;CI:0.4-1.1;t=7.18,p<0.001)。超过 30 个专科参与了幸存者的治疗(平均=1.5;CI:1.4-1.6;范围 0-6)。那些有更多晚期效应的患者看了更多的专科(r=0.51,p<0.001)。
我们证实了儿童癌症幸存者经历的广泛的晚期效应,明显大于医疗记录中记录的效应,需要多个专科的治疗。随访决策需要考虑到患者报告的发病率和关注。